The Outbreak of Cryptococcus gattii in Western North America: Epidemiology and Clinical Issues
- PMID: 21461678
- PMCID: PMC4696060
- DOI: 10.1007/s11908-011-0181-0
The Outbreak of Cryptococcus gattii in Western North America: Epidemiology and Clinical Issues
Abstract
Over the previous decade, we observed the emergence of the fungal pathogen, Cryptococcus gattii, as a cause of disease in humans and animals in a temperate climate. This outbreak, first documented on Vancouver Island, has since expanded throughout Western North America, with non-travel-associated cases now in British Columbia, Washington, Oregon, and California. Additionally, a secondary outbreak, originating in and still restricted to Oregon, has also occurred. During the past several years, several studies detailing molecular typing, virulence, antifungal susceptibilities, epidemiology, and clinical issues have been published. These studies begin to address the complex dynamics of this novel emergence of a rare and fatal fungus, outline clinical characteristics of human cases, and also opened several new areas that should be explored in the upcoming years.
Figures

Similar articles
-
Cryptococcus gattii outbreak expands into the Northwestern United States with fatal consequences.F1000 Biol Rep. 2009 Aug 17;1:62. doi: 10.3410/B1-62. F1000 Biol Rep. 2009. PMID: 20150950 Free PMC article.
-
Correlation of genotype and in vitro susceptibilities of Cryptococcus gattii strains from the Pacific Northwest of the United States.J Clin Microbiol. 2010 Feb;48(2):539-44. doi: 10.1128/JCM.01505-09. Epub 2009 Dec 9. J Clin Microbiol. 2010. PMID: 20007380 Free PMC article.
-
Emergence of Cryptococcus gattii-- Pacific Northwest, 2004-2010.MMWR Morb Mortal Wkly Rep. 2010 Jul 23;59(28):865-8. MMWR Morb Mortal Wkly Rep. 2010. PMID: 20651641
-
Searching for clues for eighteen years: Deciphering the ecological determinants of Cryptococcus gattii on Vancouver Island, British Columbia.Med Mycol. 2018 Feb 1;56(2):129-144. doi: 10.1093/mmy/myx037. Med Mycol. 2018. PMID: 28525610 Review.
-
The Disease Ecology, Epidemiology, Clinical Manifestations, and Management of Emerging Cryptococcus gattii Complex Infections.Wilderness Environ Med. 2020 Mar;31(1):101-109. doi: 10.1016/j.wem.2019.10.004. Epub 2019 Dec 6. Wilderness Environ Med. 2020. PMID: 31813737 Review.
Cited by
-
Epidemiological, Clinical and Outcome Aspects of Patients with Cryptococcosis Caused by Cryptococcus gattii from a Non-endemic Area of Brazil.Mycopathologia. 2019 Feb;184(1):65-71. doi: 10.1007/s11046-018-0304-3. Epub 2018 Nov 10. Mycopathologia. 2019. PMID: 30415450
-
Environmental distribution of Cryptococcus neoformans and C. gattii around the Mediterranean basin.FEMS Yeast Res. 2016 Jun;16(4):fow045. doi: 10.1093/femsyr/fow045. Epub 2016 May 5. FEMS Yeast Res. 2016. PMID: 27188887 Free PMC article.
-
Isavuconazole activity against Aspergillus lentulus, Neosartorya udagawae, and Cryptococcus gattii, emerging fungal pathogens with reduced azole susceptibility.J Clin Microbiol. 2013 Sep;51(9):3090-3. doi: 10.1128/JCM.01190-13. Epub 2013 Jun 26. J Clin Microbiol. 2013. PMID: 23804388 Free PMC article.
-
Cryptococcus neoformans and Cryptococcus gattii Species Complex Isolates on the Slopes of Mount Etna, SICILY, Italy.Front Microbiol. 2019 Oct 18;10:2390. doi: 10.3389/fmicb.2019.02390. eCollection 2019. Front Microbiol. 2019. PMID: 31681242 Free PMC article.
-
Treatment of Cryptococcal Meningitis: How Have We Got Here and Where are We Going?Drugs. 2022 Aug;82(12):1237-1249. doi: 10.1007/s40265-022-01757-5. Epub 2022 Sep 16. Drugs. 2022. PMID: 36112342 Free PMC article. Review.
References
-
- Cohen ML. Changing patterns of infectious disease. Nature. 2000;406:762–7. - PubMed
-
- King DA, Peckham C, Waage JK, et al. Epidemiology. Infectious diseases: preparing for the future. Science. 2006;313:1392–3. - PubMed
-
-
Galanis E, MacDougall L. Epidemiology of Cryptococcus gattii, British Columbia, Canada, 1999–2007. Emerg Infect Dis. 2010;16:251–7. This important study documents the epidemiological details of the C. gattii outbreak within British Columbia from the onset in 1999 through 2007. Interestingly, the authors found that although VGIIa predominates (>95% of cases), it does not seem to cause greater illness or death when compared to other strains. More and larger studies will be necessary to determine if clinical outcomes are different based on isolate types.
-
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous